Emmanouil Saloustros, President of the Board of Directors ΕΟΠΕ – HeSMO and Associate Professor of Oncology at University of Thessaly, shared a post on LinkedIn:
“The treatment of low-grade glioma is changing rapidly!
Advancements in molecular biology and new targeted therapies are transforming our diagnostic and therapeutic approach, making interdisciplinary collaboration more essential than ever.
It was with great pleasure that we welcomed our colleagues today to the educational webinar of ΕΟΠΕ – HeSMO on:
‘Interdisciplinary Treatment of Low-Grade Gliomas: Integrating Molecular Advances into Clinical Practice’
Through the collaboration of neurosurgeons, neuroradiologists, pathologists, radiotherapists and medical oncologists, we attempt to bridge modern scientific knowledge with daily clinical practice, with the common goal of optimal care for our patients.
Warm thanks to the Servier Hellas for its support, to the distinguished speakers Mr. Marangos, Prof. Dr. Panagiotis Papanagiotou, kostas Fountas, Evangelia Peponi, Mr. Razis and Vaia Mentesidou to the presidents of the sessions Mr. Korfia, IOANNIS KOTSANTIS, George Pissakas, Nikolaos Tsoukalas to all the participants who constantly support the educational initiatives of EOPE.
Knowledge evolves. Collaboration is what turns it into better care for patients.”
More posts featuring Emmanouil Saloustros.